Notice NOT-AR-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-EY-20-001 from the NIH Guide for Grants and Contracts

Notice NOT-AG-20-004 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Genomics Project Leader Location: Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Bioinformatics Developer Location: Cambridge, Cambridgeshire, England

Notice NOT-HS-20-001 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Senior Bioinformatics Analyst - Statistical Genetics Following the successful completion of one of the largest genomic projects the world has ever s London, England

Negotiable: Paramount Recruitment: Senior Cancer Analyst Following the successful completion of one of the largest genomic projects the world has ever seen - the 100,000 Genomes Projec London, England

Computer Science, bioinformatics, MD or Math background desired. Candidates should be a technical domain expert, with experience in healthcare, bioinformatics,…
From Foxconn Technology Group - Fri, 25 Oct 2019 08:34:56 GMT - View all Mt Pleasant, WI jobs

Funding Opportunity PAR-20-039 from the NIH Guide for Grants and Contracts. The SCORE Program is a developmental program designed to increase the research competitiveness of faculty and the research base at institutions with an explicitly stated historical mission and/or a demonstrated track record within the previous 10 years of training and graduating students from backgrounds underrepresented in biomedical research. Eligible institutions must award science degrees to undergraduate (B.S. or B.A.) and/or graduate students (M.S. or Ph.D.) and have received less than 6 million dollars per year of NIH R01 support (total costs) in each of the last 2 fiscal years.

Funding Opportunity PAR-20-040 from the NIH Guide for Grants and Contracts. The SCORE Program is a developmental program designed to increase the research competitiveness of faculty and the research base at institutions with an explicitly stated historical mission and/or a demonstrated track record within the previous 10 years of training and graduating students from backgrounds underrepresented in biomedical research. Eligible institutions must award science degrees to undergraduate (B.S. or B.A.) and/or graduate students (M.S. or Ph.D.) and have received less than 6 million dollars per year of NIH R01 support (total costs) in each of the last 2 fiscal years.

Funding Opportunity PAR-20-041 from the NIH Guide for Grants and Contracts. The SCORE Program is a developmental program designed to increase the research competitiveness of faculty and the research base at institutions with an explicitly stated historical mission and/or a demonstrated track record within the previous 10 years of training and graduating students from backgrounds underrepresented in biomedical research. Eligible institutions must award science degrees to undergraduate (B.S. or B.A.) and/or graduate students (M.S. or Ph.D.) and have received less than 6 million dollars per year of NIH R01 support (total costs) in each of the last 2 fiscal years.

Notice NOT-MH-20-001 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-002 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-20-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits renewal applications for Biobanks that will support the following NCI clinical trial programs: The NCI National Clinical Trials Network (NCTN; https://research.usc.edu/nci-national-clinical-trials-network-nctn-program/), and NCI Community Oncology Research Program (NCORP). The NCTN Biospecimen Bank (also referred to as NCTN Biobanks) will be responsible for collecting, processing, storing, and distributing well-annotated human specimens from patients with cancer who are participating in NCI-funded NCTN Phase II-III and other clinical treatment trials (CTEP/Division of Cancer Treatment and Diagnosis; DCTD). The main goal is to support NCTN with the state-of the-art banking infrastructure and operations including maintenance of up-to-date specimen inventory. The NCTN Biobanks will distribute to qualified investigators the biospecimens linked to high-quality clinical data (including treatment and outcome information) that are critical for developing and validating biomarkers for cancer diagnosis, prognosis and prediction of responses to therapy. The NCTN Biobanks will work in collaboration with NCTN Groups and Group Statistical and Data Management Centers as well as affiliated institutions to ensure effective operation. Each Biobank needs to maintain association with one specific NCTN Group and needs to be endorsed in that role by the group leaders. NCTN Biobanks will also support biobanking and storage of biospecimens from NCORP cancer control and prevention trials (NCORP/Division of Cancer Prevention; DCP).

Notice NOT-AA-19-029 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-036 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support grants to improve understanding of viral suppression and HIV transmission in the United States (U.S.) using population-level epidemiology, novel tools from data science approaches and m/eHealth, and implementation science research. Data generated through this research will be used to inform and evaluate context-specific HIV control strategies towards the goal of ending the HIV epidemic in the U.S.

Funding Opportunity PAR-20-042 from the NIH Guide for Grants and Contracts. The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. The research must be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems (including stroke, traumatic brain injury, spinal cord injury, and orthopedic conditions); repair and recovery of motor and cognitive function; functional plasticity, adaptation, and windows of opportunity for rehabilitative interventions; rehabilitative strategies involving pharmaceutical, stimulation, and neuroengineering approaches, exercise, motor training, and behavioral modifications; pediatric rehabilitation; secondary conditions associated with chronic disabilities; improved diagnosis, assessment, and outcome measures; and development of orthotics, prosthetics, and other assistive technologies and devices. The NCMRR ECR Award R03 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new technology. Irrespective of the type of project, the intent of the NCMRR ECR Award R03 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.

Funding Opportunity RFA-MH-20-320 from the NIH Guide for Grants and Contracts. The goal of this initiative is to support the identification, validation and manipulation of neural circuits that underlie cognitive, emotional, and social processes impacted in mental illnesses including alcohol use disorder and other substance abuse. The initiative is focused on probing circuit mechanisms underlying neuro-psychiatrically relevant behavior through studies in non-human primates. This initiative is intended to complement existing institute-funded preclinical investigation of circuits which have often focused on smaller brains.

Notice NOT-LM-20-001 from the NIH Guide for Grants and Contracts